60 Degrees Pharmaceuticals, Inc. (SXTP)

Altair Engineering Revenue

60 Degrees Pharmaceuticals had revenue of $256.28K in the quarter ending March 31, 2025, with 89.41% growth. This brings the company's revenue in the last twelve months to $802.32K, up 118.37% year-over-year. In the year 2024, 60 Degrees Pharmaceuticals had annual revenue of $681.35K with 168.70% growth.

• Revenue (ttm): $802.32K
• Revenue Growth: +118.37%
• P/S Ratio: 1.27
• Revenue / Employee: $267,441
• Employees: 3
• Market Cap: 4.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	681.35K	427.77K	168.70%
Dec 31, 2023	253.57K	-257.64K	-50.40%
Dec 31, 2022	511.21K	-5.84M	-91.95%
Dec 31, 2021	6.35M	3.80M	149.18%
Dec 31, 2020	2.55M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.